| Source: |
| Type: |
| Blood-Brain Barrier(BBB) is a term often used regarding if a product has the ability to cross the BBB. |
| 3537- | 5-HTP, | 5-Hydroxytryptophan: a clinically-effective serotonin precursor |
| - | Review, | NA, | NA |
| 3538- | 5-HTP, | Oral Administration of 5-Hydroxytryptophan Restores Gut Microbiota Dysbiosis in a Mouse Model of Depression |
| - | in-vivo, | Nor, | NA |
| 5288- | 5-HTP, | The Impact of 5-Hydroxytryptophan Supplementation on Cognitive Function and Mood in Singapore Older Adults: A Randomized Controlled Trial |
| - | Trial, | AD, | NA |
| 5312- | acet, | Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action |
| 3864- | ACNs, | Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4368- | AgNPs, | Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro |
| - | NA, | Nor, | NA |
| 4549- | AgNPs, | Silver nanoparticles: Synthesis, medical applications and biosafety |
| - | Review, | Var, | NA | - | Review, | Diabetic, | NA |
| 4583- | AgNPs, | Metal-Based Nanoparticles for Cardiovascular Diseases |
| - | Review, | NA, | NA |
| 306- | AgNPs, | Cancer Therapy by Silver Nanoparticles: Fiction or Reality? |
| - | Analysis, | NA, | NA |
| 2660- | AL, | Allicin: A review of its important pharmacological activities |
| - | Review, | AD, | NA | - | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 3269- | ALA, | Sulfur-containing therapeutics in the treatment of Alzheimer’s disease |
| - | NA, | AD, | NA |
| 3271- | ALA, | Decrypting the potential role of α-lipoic acid in Alzheimer's disease |
| - | Review, | AD, | NA |
| 3272- | ALA, | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
| - | Review, | AD, | NA |
| 3284- | ALA, | Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson's Disease Model Induced by 6-OHDA |
| - | vitro+vivo, | Park, | NA |
| 3444- | ALA, | Alpha-Lipoic Acid Nootropic Review: Benefits, Use, Dosage & Side Effects |
| - | Review, | NA, | NA |
| 3539- | ALA, | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
| - | Review, | AD, | NA |
| 3541- | ALA, | Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology |
| - | Review, | Var, | NA |
| 3542- | ALA, | Chelation: Harnessing and Enhancing Heavy Metal Detoxification—A Review |
| - | Review, | Var, | NA |
| 3550- | ALA, | Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease? |
| - | Review, | AD, | NA |
| 3549- | ALA, | Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia |
| - | Review, | AD, | NA |
| 3548- | ALA, | How Alpha Linolenic Acid May Sustain Blood–Brain Barrier Integrity and Boost Brain Resilience against Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 3546- | ALA, | Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study |
| - | Study, | AD, | NA |
| 3544- | ALA, | Alpha lipoic acid for dementia |
| - | Review, | AD, | NA |
| 5317- | ALC, | Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2 |
| - | in-vivo, | Nor, | NA |
| 5360- | almon, | BEV, | Case report: Almonertinib in combination with bevacizumab for leptomeningeal metastases from epidermal growth factor receptor-mutation non-small cell lung cancer: Case series |
| - | Case Report, | NSCLC, | NA |
| 5358- | almon, | Experimental Study of Almonertinib Crossing the Blood-Brain Barrier in EGFR-Mutant NSCLC Brain Metastasis and Spinal Cord Metastasis Models |
| - | vitro+vivo, | NSCLC, | NA |
| 4279- | Api, | The Beneficial Role of Apigenin against Cognitive and Neurobehavioural Dysfunction: A Systematic Review of Preclinical Investigations |
| - | Review, | NA, | NA |
| 4280- | Api, | Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3887- | Api, | The flavonoid apigenin protects brain neurovascular coupling against amyloid-β₂₅₋₃₅-induced toxicity in mice |
| - | in-vivo, | AD, | NA |
| 3822- | Aroma, | Aromatherapy in the treatment of Alzheimer's disease: A systematic review |
| - | Review, | AD, | NA |
| 4303- | Ash, | Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review |
| - | Review, | AD, | NA |
| 5425- | ASTX, | Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights |
| - | in-vivo, | AD, | NA |
| 5508- | Ba, | Neuroprotective effects of baicalin and baicalein on the central nervous system and the underlying mechanisms |
| - | Review, | Stroke, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
| 2605- | Ba, | BA, | Potential therapeutic effects of baicalin and baicalein |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 2673- | BBR, | Therapeutic potential and recent delivery systems of berberine: A wonder molecule |
| - | Review, | Var, | NA |
| 3677- | BBR, | Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 3678- | BBR, | Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model |
| - | Review, | AD, | NA |
| 3680- | BBR, | Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway |
| - | in-vivo, | AD, | NA |
| 2731- | BetA, | Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives |
| - | Review, | GBM, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
| 5561- | betaCar, | Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 5563- | betaCar, | Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease |
| - | Review, | AD, | NA |
| 5692- | BJ, | Seed oil of Brucea javanica induces apoptosis through the PI3K/Akt signaling pathway in acute lymphocytic leukemia Jurkat cells |
| - | vitro+vivo, | AML, | NA |
| 5473- | BM, | Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability |
| - | in-vivo, | AD, | NA | - | in-vivo, | Park, | NA |
| 3697- | BM, | Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies |
| - | Review, | AD, | NA |
| 5659- | BNL, | Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood–brain barrier permeability: a preclinical systematic review and meta-analysis |
| - | Review, | Var, | NA |
| - | vitro+vivo, | GBM, | U251 |
| 5656- | BNL, | Role of borneol as enhancer in drug formulation: A review |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 5649- | BNL, | Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability |
| - | Review, | Nor, | NA |
| 5660- | BNL, | Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System |
| - | Review, | Var, | NA |
| 5665- | BNL, | Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies |
| - | in-vivo, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1123 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid